FIELD: medicine.
SUBSTANCE: method comprises the study of ezrin expression and the process of methylation of genes in the endometrium. In case of increased expression of ezrin in cell cytoplasm from 4 to 6 points and reduction of the process of methylation of genes under the influence of O6- methylguanil-DNA of methyltransferase (MGMT) to the level of no more than 2 points the possibility is determined of malignant pathological process and occurrence of endometrioid adenocarcinoma.
EFFECT: use of invention enables to increase the efficiency of differential diagnostics and prognosis of endometrial cancer in patients of perimenopausal period.
4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING HYSTERECTOMY INDICATIONS IN ENDOMETRIUM HYPERPLASIA CASES | 2006 |
|
RU2310857C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTIC OF HIGH-GRADE DIFFERENTIATED ADENOCARCINOMAS AND ADENOMAS OF COLON | 2015 |
|
RU2599101C1 |
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
| METHOD FOR PREDICTION OF MODERATELY DIFFERENTIATED ENDOMETRIOID UTERINE BODY T1N0M0 CARCINOMA COURSE IN CASE OF PRIMARY TUMOUR SIZE WITHIN 1 cm | 2015 |
|
RU2619214C1 |
| METHOD FOR EVALUATING RISK OF ENDOMETRIAL CANCER | 2014 |
|
RU2558059C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF ENDOMETRIAL CYSTS AFTER SURGICAL TREATMENT BY MEANS OF IMMUNOHISTOCHEMICAL MARKERS | 2017 |
|
RU2681219C1 |
| DIAGNOSTIC TECHNIQUE IN COMPLEX ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA | 2011 |
|
RU2459211C1 |
| METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
| PREDICTION OF DEVELOPMENT OF COMMON FORMS OF INFILTRATIVE ENDOMETRIOSISS BASED ON EVALUATION OF CD15 EXPRESSION IN ENDOMETRIC BIOPSY MATERIALS | 2016 |
|
RU2634263C1 |
| METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
